AI-generated summary
The authors review near infrared light therapy (NILT) as a possible acute stroke treatment. They report that it improved long-term outcomes in various preclinical animal stroke models and was reported as effective and safe in the phase II NEST-1 trial in acute stroke patients. The authors state that confirmation by the NEST-II trial is still needed.
- Who or what was studied
- Acute stroke patients in the NEST-1 phase II trial, and preclinical animal stroke models
- Limits stated in the abstract
- The abstract describes preliminary results from a single phase II trial and states that the findings still require confirmation by NEST-II.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Stroke, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.